Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Controls for Respiratory Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03120481
Recruitment Status : Recruiting
First Posted : April 19, 2017
Last Update Posted : April 19, 2017
Sponsor:
Information provided by (Responsible Party):
Chang-Hoon Lee, Seoul National University Hospital

Brief Summary:
This is the registry of control participants for patients with various respiratory diseases. We screened healthy volunteers who visited Seoul National Hospital Healthcare System Gangnam Center for routine health check-up, and enrolled patients who agree to participate in the study. The participants undergo baseline questionnaires, provide blood specimen and information of the results of health check-up. We will include participants as controls if they have no significant respiratory symptom and no significant radiographic abnormality. The data from this registry will be compared with those from other registry of various respiratory diseases

Condition or disease Intervention/treatment
Chronic Obstructive Pulmonary Disease Asthma Idiopathic Pulmonary Fibrosis Nontuberculous Mycobacterium Infection Bronchiectasis Lung Cancer Other: no intervation

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 1572 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 20 Years
Official Title: The Registry of Controls for Respiratory Diseases
Actual Study Start Date : April 10, 2017
Estimated Primary Completion Date : February 28, 2037
Estimated Study Completion Date : February 28, 2037


Group/Cohort Intervention/treatment
Normal control Other: no intervation
no intervention




Primary Outcome Measures :
  1. Mortality [ Time Frame: 20 years ]
    Death


Secondary Outcome Measures :
  1. Hospitalization [ Time Frame: 20 years ]
    All cause hospitalization

  2. Respiratory hospitalization [ Time Frame: 20 years ]
    Hospitalization from respiratory causes

  3. Respiratory diseases diagnosis [ Time Frame: 20 years ]
    Respiratory diseases diagnosis


Biospecimen Retention:   Samples With DNA
DNA Plasma Serum


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   19 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Those who visited the hospital for health check-up, and agree to participate in this study.
Criteria

Inclusion Criteria:

  • 19-90 years old male and female
  • underwent health check-up including chest radiography
  • obtained informed consent

Exclusion Criteria:

  • those who showed a significant abnormal finding of chest radiography
  • those who reported a significant respiratory symptoms

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03120481


Contacts
Layout table for location contacts
Contact: Chang-Hoon Lee, M.D. 82-2-2072-4743 kauri670@gmail.com

Locations
Layout table for location information
Korea, Republic of
Seoul National University Healthcare System Gangnam Center Recruiting
Seoul, Korea, Republic of, 06236
Contact: Chang-Hoon Lee, M.D.    82-2-2072-4743    kauri670@gmail.com   
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Layout table for investigator information
Principal Investigator: Chang-Hoon Lee, M.D. Seoul National University Hospital

Additional Information:

Layout table for additonal information
Responsible Party: Chang-Hoon Lee, Associate professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT03120481    
Other Study ID Numbers: 2016-3435
First Posted: April 19, 2017    Key Record Dates
Last Update Posted: April 19, 2017
Last Verified: April 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Mycobacterium Infections
Mycobacterium Infections, Nontuberculous
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Bronchiectasis
Respiration Disorders
Respiratory Tract Diseases
Lung Diseases
Idiopathic Interstitial Pneumonias
Lung Diseases, Interstitial
Bronchial Diseases
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections